Statistics for Systemic CD4 immunity: a powerful clinical biomarker for PD-L1/PD-1 immunotherapy
Total visits
| views | |
|---|---|
| Systemic CD4 immunity: a powerful clinical biomarker for PD-L1/PD-1 immunotherapy | 178 |
Total visits per month
| views | |
|---|---|
| February 2025 | 1 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
File Visits
| views | |
|---|---|
| 2020101062_Zuazo_SystemicCD4.pdf | 178 |
Top country views
| views | |
|---|---|
| United States | 127 |
| Sweden | 8 |
| Spain | 7 |
| China | 5 |
| Germany | 5 |
| France | 2 |
| United Kingdom | 2 |
| Russia | 2 |
| Ukraine | 2 |
| India | 1 |
| Iran | 1 |
| South Korea | 1 |
| Slovenia | 1 |
| Slovakia | 1 |
| Uruguay | 1 |
Top city views
| views | |
|---|---|
| Fairfield | 28 |
| Ashburn | 18 |
| Oakland | 17 |
| Wilmington | 16 |
| San Diego | 9 |
| Houston | 6 |
| Mountain View | 5 |
| Cambridge | 2 |
| Fremont | 2 |
| Fuzhou | 2 |
| Redmond | 2 |
| Redwood City | 2 |
| Santa Cruz | 2 |
| Tustin | 2 |
| Beijing | 1 |
| Bratislava | 1 |
| Menlo Park | 1 |
| Monmouth Junction | 1 |
| Montevideo | 1 |
| Norwalk | 1 |
| Tobolsk | 1 |